Clinical trial
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
NCT00003536
Study timeline
Registry last updated2013-07-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Stage IV Breast Cancerunresolved
Recurrent Breast Cancerunresolved
Interventions
methotrexateDRUG · verified · RxNorm: methotrexate
alternative product therapyPROCEDURE
biological therapyPROCEDURE
biologically based therapiesPROCEDURE
cancer prevention interventionPROCEDURE
chemotherapyPROCEDURE
differentiation therapyPROCEDURE
Sponsors & collaborators
Burzynski Research Institutelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00003536 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.